anti-CD19 CAR T-cells
/ Vinmec
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 27, 2025
CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia
(clinicaltrials.gov)
- P1 | N=18 | Completed | Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology | Recruiting ➔ Completed
Trial completion • Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • B Cell Lymphoma • B Cell Non-Hodgkin Lymphoma • Hematological Malignancies • Leukemia • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology
September 07, 2023
CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia
(clinicaltrials.gov)
- P1 | N=16 | Recruiting | Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology
CAR T-Cell Therapy • New P1 trial • Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • Hematological Malignancies • Leukemia • Lymphoma • Non-Hodgkin’s Lymphoma • Oncology
1 to 2
Of
2
Go to page
1